
Why Some GLP-1 Users Get Digestive Issues
It’s not uncommon for people on GLP-1 medications to report side effects like constipation, gas, or nausea. But what if these aren’t just side effects — what if they’re signals from your gut microbiome?
The Mechanism: Slower Digestion = Different Bacteria
GLP-1 agonists slow gastric emptying. That gives your gut more time to ferment food — which changes how bacteria grow. In some cases, this supports healthy bacteria that thrive on fiber. In others, it can lead to overgrowth of gas-producing or opportunistic microbes.
Key Bacteria Involved
-
Methanobrevibacter smithii: This microbe produces methane, which can slow down digestion and may contribute to constipation in some people.
-
Lactobacillus reuteri: This beneficial strain may increase with GLP-1 use and is known to help support the gut lining and reduce inflammation.
Changes in these and other microbes could influence how your body responds to GLP-1 medications — and might explain why digestion feels different.
Symptoms That Might Point to Microbial Imbalance
-
Persistent bloating
-
New constipation
-
Stronger food sensitivities
How Testing Can Help
If you’re unsure whether your symptoms are medication-related or microbial, a gut microbiome test can reveal overgrowths, inflammation markers, and diversity issues. Based on results, dietary adjustments or specific probiotic strains may offer relief.
References
-
Thomas, L. (2025). GLP-1 Agonists May Reshape the Gut Microbiome. News Medical Life Sciences. https://www.news-medical.net/news/20250411/GLP-1-agonists-may-reshape-the-gut-microbiome.aspx
-
Zhu, Y. et al. (2021). Association of Methanobrevibacter smithii with constipation in adults. Gut Microbes, 13(1), 1–10. https://doi.org/10.1080/19490976.2021.1887723
-
Hall, A. B. et al. (2017). A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Cell Host & Microbe, 21(6), 730–742. https://doi.org/10.1016/j.chom.2017.05.002
-
Spinler, J. K. et al. (2017). Human-derived probiotic Lactobacillus reuteri strains differentially modulate inflammation and microbial ecology. Frontiers in Microbiology, 8, 96. https://doi.org/10.3389/fmicb.2017.0009